Advertisement

Reactions Weekly

, Volume 1709, Issue 1, pp 228–228 | Cite as

Rivoceranib

Various toxicites: case report
Case report
  • 13 Downloads

Reference

  1. Yang L, et al. Apatinib treatment for KIT- and KDR-amplified angiosarcoma: A case report. BMC Cancer 18: 31 May 2018. Available from: URL: http://doi.org/10.1186/s12885-018-4523-2 - China

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations